Introduction
Diabetes mellitus is of increasing concern as the prevalence continues to increase worldwide and is estimated to reach 8% of the adult population in 2030 [1] . A major health issue is the ensuing increased risk of developing cardiovascular (CV) complications in type 2 diabetes with its consequent risk of increased morbidity and mortality. Ankle brachial index (ABI) has previously been shown to correlate to cardiovascular comorbidity and its´ benefits has been highlighted, in addition to the Framingham risk score, in clinical practice [2] [3] [4] . Indeed ABI has been pointed out as one of the most feasible screening methods for cardiovascular disease (CVD) since it is easy to perform and also inexpensive [5, 6] . A drawback is the risk of falsely high values due to stiffened, calcified ankle arteries which is mostly found in subjects with diabetes [3, 4, 7, 8] . This group, with falsely high ABI has shown an equal or even higher mortality risk than low ABI why this group is important to detect [9, 10] . As the arteries of the great toe rarely are involved in the calcification process, assessing toe brachial index (TBI) could provide a more accurate risk evaluation [3, 4, 7, 8] .
Peripheral arterial disease (PAD) is common in diabetes mellitus, causing suffering and high costs by ulcerations and chronic pain as well as risk for need of limb amputations.
Furthermore, PAD is associated with increased mortality [3, 11] . Early interventions are important and can decrease the risk of complications [4] . Taken together, measuring TBI seems important for detecting PAD and might also help assessing general vascular status in subjects with type 2 diabetes.
Health care is mostly publicly financed in Sweden, with a small individual contribution of about 300 USD per year. Routine controls for patients with type 2 diabetes are mainly performed in the primary care. All diabetes care, primary as well as hospital based, adhere to the same national guidelines. It is fundamental to gain more insight on how to best assess the risk of different risk factors in subjects with type 2 diabetes since this group of patients have a substantially increased risk for premature cardiovascular morbidity and mortality.
Aortic pulse wave velocity (PWV) measured by tonometry provides a non-invasive estimate of arterial stiffness and is an independent predictive risk factor for all-cause mortality and cardiovascular mortality [12, 13] . To the best of our knowledge, the association between PWV and TBI in a larger group of patients with type 2 diabetes has previously not been explored. Intima media thickness (IMT) of the carotid arteries measured by B-mode ultrasound is a well known, non-invasive marker of subclinical atherosclerosis and increased risk of CV morbidity [14, 15] .
Most studies on PAD and CVD risk are based on ABI. The present study focuses on the association between TBI and vascular organ damage and cardiovascular comorbidities reporting data from a large cohort of 742 middle-aged patients with type 2 diabetes compared to data from non-diabetic controls.
Methods

Settings
The study was conducted as part of CARDIPP (Cardiovascular Risk factors in Patients with Diabetes -a Prospective study in Primary care) analyzing the baseline data from all patients where toe pressure (TP) measurements were conducted. CARDIPP was launched 2005 to evaluate the prevalence and early risk markers for cardiovascular disease and was designed as an observational prospective study [16, 17] . The patient enrolment was performed during 2005-2008 and included middle aged (54-66 years) patients with type 2 diabetes, independent of diabetes duration or previous CV burden, consecutively recruited from 22 different primary health care centres in the counties of Östergötland and Jönköping. Patients with severe medical conditions (e.g. terminal cancer) or severe mental disorder were excluded from participation. The catchment area included smaller/middle-sized cities (<150.000 inhabitants) as well as rural areas. As non-diabetic controls, we used age-matched participants from the CAREFUL (Cardiovascular Reference Population) study, i.e. a parallel study to CARDIPP including middle-aged non-diabetic individuals who were subjected to the same study protocol as participants in CARDIPP [18] . The CAREFUL study included randomly selected individuals from a population register aged 50-70 years from the Linköping catchment area.
Individuals with known diabetes were excluded as were those with a family history or own diagnosis of aortic aneurysm.
Measures
All patients were seen on an extended yearly check up at the primary health care centres. In addition, the patients underwent an extensive physiological investigation at the department of Physiology at Linköping University hospital or at Ryhov Hospital (Jönköping), respectively.
At the check-up, history of cardiovascular diseases, current medication and life style was recorded.
Laboratory Measures
Blood samples were obtained in the morning after an overnight fast. The laboratory tests were all analyzed by laboratories at the local primary care centres or hospitals except for apolipoproteins which were analyzed at Linköping University Hospital (Department of Laboratory Medicine). HbA1c was analyzed according to the Swedish Mono-S HPLC standard which is approximately one percent unit lower than the Diabetes Control and Complications Trial (DCCT) standard. Glomerular filtration rate (GFR) was analysed according to Cockcroft-Gault, MDRD as well as cystatinC estimated. In the regression analyses Cockcroft-Gault estimated GFR was used. Pulse wave velocity (PWV) in carotid-femoral arteries (PWVcf), i.e. indicating central arterial stiffness, and carotid-radial arteries (PWVcr) was calculated using pulse wave transit time (electrocardiogram-gated recordings of arterial pulse waves in the carotid, radial and femoral artery, respectively) and the distance between the suprasternal notch and the carotid, radial and femoral measurement sites as described in detail previously [16] . A Millar pressure tonometer and the Sphygmo-Cor system (Model MM3, AtCor Medical, Sydney, Australia) were used.
Left ventricular mass (LVM) was measured as described by Devereux [19] with the patient in a left semi-lateral position when performing echocardiography. Basic measurements of the dimensions (left ventricle in diastole and systole, and inter-ventricular septum thickness and posterior wall thickness in diastole) were done in M-mode (The ultrasound scanner was a GE Vivid 7, GE Healthcare, Milwaukee, USA). Left ventricular mass was indexed to body surface area (LVMI) and expressed in g/m 2 .
A B-mode Ultra sound (HDI 5000, ALT,Bothell, Wa, USA) with a broadband linear transducer was used to record intima-media thickness (IMT) of the carotid arteries as described in detail earlier [17] . In brief, three images were captured bilaterally during diastole and transferred to a PC for further analyses. Measurement of IMT was made by manually delimiting the border between lumen/intima as well as media/adventitia in the images. An average of the measurements on the left and the right carotid arteries was used in the further calculations. Following IMT measurement, the presence of carotid plaque was determined.
This was done in the carotid bifurcation. A plaque thickness exceeding 1 mm or 50% thicker than adjacent segments was considered significant.
Statistics
IBM SPSS Statistics version 19.0 was used for statistic analysis. Independent t-test was used
when comparing means between two groups and ANOVA when comparing means of three groups (Scheffe was used as post hoc test). Pearson correlation was used to test correlation between TBI and vascular, descriptive as well as laborative measures. Logistic and linear regression was applied to further analyse the relation of TBI to aortic PWV, IMT and carotid plaque. P-value <0.05 was considered statistically significant.
Ethical
The study was in line with the principles in the Declaration of Helsinki and was approved by the Regional Ethical Review Board in Linköping. Informed consent was obtained from all participants.
Results
General
For patient characteristics see table 1. In total 742 patients with diabetes mellitus type 2 were included. There were more men (n=482) than women (n=260). Median duration of diabetes was 6 years and most of the patients (77%) had a duration of less than 10 years. Eighty eight percent of the subjects were overweight or obese as defined by a BMI > 25 kg/m 2 , and 56% had a BMI >30 kg/m 2 . About one third (31%) were prescribed insulin alone or in combination with oral anti-diabetics, 41% had oral glucose lowering drugs and 28% were treated with diet only. About two thirds (65%) were prescribed anti-hypertensive drugs (also including other causes of prescription, i.e. heart failure, micro-albuminuria) while 55% received lipid lowering medication (statins) and 29% acetylsalicylic acid (ASA). Eighteen percent of the patients were current smokers, while 49% were previous smokers and 32% had never smoked.
Swedish moist tobacco was used by 11% of the patients.
None of the patients had undergone amputation of a lower limb or toe, but two patients had ulcerations in one of the great toes at the physiological examination thus preventing the performance of measurement bilaterally. In these two cases the measurement from the unaffected great toe was used.
A low TBI, i.e. < 0.7, was seen in 22% of the patients, but only one (0.13%) had a severe reduction (TBI < 0.3). The lowest TBI found was 0.21 and the lowest TP was 25 mmHg.
As shown in figure 1 , TBI correlated negatively with the duration of diabetes (r= -0.167, (table 2) .
No significant correlations were seen between TBI and left ventricular mass index or PWVcr.
Comorbidity and medication
The prevalence of previous cardiovascular events was relatively low ( 
Laboratory data
Metabolic control, as estimated by a baseline HbA1c, correlated negatively to TBI in patients with diabetes as shown in figure 3 . The association remained statistically significant after 
Controls
As controls, 155 non-diabetic individuals were included. and PVW model2 p=0.10).
Discussion
The present study, focusing on TBI, included a large number of middle-aged patients with type 2 diabetes. Though none of the patients had undergone amputation, 22% were found to have a TBI below 0.7 in one of the toes, thus indicating PAD [7, 8, 20] and an increased risk of future need of vascular interventions. TBI was significantly lower in the patients with type 2 diabetes than in the controls. In the control group 13% had a TBI < 0.7 which is similar or slightly higher than earlier reports on PAD frequency as measured by ABI [3, 4, 21, 22] .
Taken together the present study suggests a higher prevalence of PAD in patients with diabetes than in the general population indicating that about one fifth of middle aged patients with type 2 diabetes have subclinical signs of PAD.
Similar to earlier reports on PAD (mainly evaluated by ABI) [2, 3, 5, 7, 23] , patients with diabetes with a low TBI were found to have a higher prevalence of ischemic events. In support of these findings, the present study showed an association between peripheral vascular disease, as established by low TBI, and central vascular disease, defined as increased central arterial stiffness, elevated IMT and presence of carotid plaques. Central arterial stiffness has previously been associated to PAD assessed by ABI in the general population [23] [24] [25] , but has, to the best of our knowledge, not been studied regarding TBI in a larger group of patients with type 2 diabetes. Both central arterial stiffness and IMT was independently negatively connected to TBI. The associations seemed stronger in diabetes than in controls and was independent of diabetes duration, age, previous ischemic events and kidney function, all factors known to influence vascular disease.
PAD, as defined by TBI <0.64 (thus slightly lower than in our study), was present in 15% of the patients in a study by Poulsen et al analysing 305 patients with type 2 diabetes, >20 years old, without a history of CVD [26] . Seventy eight percent had, in addition to PAD, objective signs of ischemic heart disease and/or carotid arterial disease (assessed by myocardial perfusion scintigraphy and IMT, respectively). As subjects with a history of previous ischemic events were excluded from the study, this strengthens the observation of an often asymptomatic and generalized disease in patients with type 2 diabetes.
In general, hyperlipidemia is considered to increase the risk of vascular events, including PAD [3, 20] . However, the present study could not find a correlation to TBI even when correcting for lipid lowering drugs, heart failure, diabetes duration as well as for age (data not shown). Similar observations have previously been made in diabetes where PAD was diagnosed by ABI [23] .
Smokers had a lower TBI, which is in accordance with earlier findings where PAD was found to be more common in smokers [3, 4, 20] . However, previous smokers did not show a lower TBI nor did the patients using Swedish moist tobacco (non-smokable oral form of tobacco).
Patients with diabetes and/or renal insufficiency have a higher risk of PAD and other CV diseases [3, 4, 20, 23, 27, 28] . Accordingly, we found a correlation between low GFR and a low TBI. The association between PAD and albuminuria has previously shown conflicting results [23, [29] [30] [31] . Our study could not find any correlation between TBI and the albumin/creatinine ratio.
In conclusion, PAD was present in about one fifth of the patients in an unselected middle- 
